Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 14/20 | 0.47 |
| ▸ | CRHBP | P24387 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8407001 | 0.80 | ALDH1A1 (0.39) | ALDH1A1CRHBPCRHR2SMN1; SMN2MAPT | |
| SCHEMBL17887331 | 0.76 | MAPT (0.41) | ALDH1A1CRHBPCRHR2SMN1; SMN2MAPT | |
| SCHEMBL9889241 | 0.74 | APP (0.50) | ALDH1A1CRHBPCRHR2SMN1; SMN2MAPT | |
| SCHEMBL9730908 | 0.73 | — | — | |
| SCHEMBL12041925 | 0.72 | ALDH1A1 (0.45) | ALDH1A1CRHBPCRHR2SMN1; SMN2APP | |
| SCHEMBL5171537 | 0.70 | PTPN1 (0.45) | ALDH1A1CRHBPCRHR2SMN1; SMN2TSHR | |
| SCHEMBL18098832 | 0.70 | ALDH1A1 (0.44) | ALDH1A1CRHBPCRHR2SMN1; SMN2TSHR | |
| SCHEMBL796744 | 0.68 | KMT2A (0.44) | ALDH1A1CRHBPCRHR2SMN1; SMN2TSHR | |
| SCHEMBL13467414 | 0.67 | ALDH1A1 (0.42) | ALDH1A1CRHBPCRHR2SMN1; SMN2APP | |
| SCHEMBL3077632 | 0.67 | PTPN1 (0.47) | ALDH1A1CRHBPCRHR2SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | claimed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | claimed |
| EP-3445826-B1 | RADIATION CURABLE INK FORMULATION | FLINT GROUP GERMANY GMBH (DE) | 2021-07-14 | — | — | EP | disclosed |
| US-20190106583-A1 | RADIATION CURABLE INK FORMULATION | FLINT GROUP SWEDEN AB (SE) | 2019-04-11 | — | — | US | disclosed |
| WO-2017182638-A1 | RADIATION CURABLE INK FORMULATION | FLINT GROUP GERMANY GMBH (DE) | 2017-10-26 | — | — | WO | disclosed |
| US-7790882-B2 | Monophosphine compound, transition metal complex thereof and production method of optically active compound using the complex as asymmetric catalyst | Carreira, Erick M. (CH) | 2010-09-07 | — | — | US | disclosed |
| US-20050277772-A1 | Monophosphine compound, transition metal complex thereof and production method of optically active compound using the complex as asymmetric catalyst | Carreira, Erick (CH) | 2005-12-15 | — | — | US | disclosed |
| US-6461417-B1 | Ink compositions | XEROX CORPORATION | 2002-10-08 | — | — | US | disclosed |
| US-6117223-A | Hot melt inks containing polyketones | XEROX CORPORATION (US) | 2000-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277772-A1 | Monophosphine compound, transition metal complex thereof and production method of optically active compound using the complex as asymmetric catalyst | C1R, ARL1, C5 | ALDH1A1 2507/4885CRHBP 4732/4885CRHR2 3803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.